 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Applied DNA Sciences receives Linea DNA follow-on order

STONY BROOK, NY / ACCESSWIRE / November 28, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ('Applied DNA' or the 'Company'), a leader in PCR-based DNA technologies, today announced the receipt of a...

Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application

Applied DNA Sciences (APDN Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCar...

Applied DNA Sciences' Expansion into saRNA: A Significant Development Bolstering mRNA Therapeutics

- Extension Increases Total Addressable Market to Include Both Conventional Non-Amplifying mRNA and saRNA -- Extension Enabled by the Company's Ongoing Platform Development and Optimization -STONY...

Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)

Applied DNA Sciences ships first saRNA IVT template generated by Linea platform

- Preclinical Orders for Additional Customers Underway -STONY BROOK, NY / ACCESSWIRE / November 9, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ('Applied DNA' or the 'Company'), a leader in...

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

Agreement Focuses on the Accelerated Development of LNP-encapsulated LineaDNA&amp;trade; Vaccines to Eliminate the Use of Plasmid DNA and Reduce the Dependence on Extreme Cold Chains of Today's...

Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals

Experienced Biopharma/Pharmaceutical Executive to Lead Implementation of cGMP-quality LineaDNA&amp;trade; Capability for IVT mRNA ProductionPreviously Led Manufacturing Operations Scale-up for...

Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs

STONY BROOK, NY / ACCESSWIRE / August 29, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the general availability of Linea&trade; IVT platform evaluation kits (the "Kit") and...

Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit

STONY BROOK, NY / ACCESSWIRE / August 23, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ('Applied DNA' or the 'Company'), a leader in PCR-based DNA technologies, today announced...

Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production

Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment consists of the manufacture of DNA for use in nucleic acid-based therapeutics. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Watchers	21,004
52-Wk Low	$0.75
52-Wk High	$1.93

Market Cap	$12.96M
Volume (M)	60,893.00
52-Wk High	$1.93
52-Wk Low	$0.75

APDN Applied Dna Sciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals